New hope for kids with tough lymphoma: stronger chemo and targeted drug tested
NCT ID NCT02405676
Summary
This study aims to improve survival for children and adolescents with advanced B-cell lymphoma. It tests whether adding a targeted drug called rituximab and using higher doses of chemotherapy works better than previous treatments. The goal is to help patients with more severe forms of the disease live longer without their cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATURE B-CELL NON-HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
West China Second University Hospital of Sichuan University
Chengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.